Rik Rozemeijer

MD, PharmD

Department of Cardiology, University Medical Centre Utrecht, Utrecht, the Netherlands

Expertise

Intervention

Articles by Rik Rozemeijer, MD, PharmD

Duration of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention: Is Less More?

Rik Rozemeijer, Wijnand P van Bezouwen, Michiel Voskuil, et al

Citation: US Cardiology Review 2018;12(2):91–7.

DOI:

https://doi.org/10.15420/usc.2018.4.2